{"data":[{"accessionNo":"0001193125-26-225997","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001719406","issuerName":"NRX Pharmaceuticals, Inc.","ticker":"NRXP","cusip":"629444209","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Anson Funds Management LP","reportingCik":null,"personType":null,"sharesOwned":1736737,"percentOfClass":4.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/nrxp"},{"accessionNo":"0001193125-26-225997","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001719406","issuerName":"NRX Pharmaceuticals, Inc.","ticker":"NRXP","cusip":"629444209","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Anson Management GP LLC","reportingCik":null,"personType":null,"sharesOwned":1736737,"percentOfClass":4.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/nrxp"},{"accessionNo":"0001193125-26-225997","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001719406","issuerName":"NRX Pharmaceuticals, Inc.","ticker":"NRXP","cusip":"629444209","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Tony Moore","reportingCik":null,"personType":null,"sharesOwned":1736737,"percentOfClass":4.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/nrxp"},{"accessionNo":"0001193125-26-225997","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001719406","issuerName":"NRX Pharmaceuticals, Inc.","ticker":"NRXP","cusip":"629444209","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Anson Advisors Inc.","reportingCik":null,"personType":null,"sharesOwned":1736737,"percentOfClass":4.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/nrxp"},{"accessionNo":"0001193125-26-225997","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001719406","issuerName":"NRX Pharmaceuticals, Inc.","ticker":"NRXP","cusip":"629444209","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Amin Nathoo","reportingCik":null,"personType":null,"sharesOwned":1736737,"percentOfClass":4.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/nrxp"},{"accessionNo":"0001193125-26-225997","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001719406","issuerName":"NRX Pharmaceuticals, Inc.","ticker":"NRXP","cusip":"629444209","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Moez Kassam","reportingCik":null,"personType":null,"sharesOwned":1736737,"percentOfClass":4.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/nrxp"}],"updatedAt":"2026-11-03T20:30:26.942Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/nrxp","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}